Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 380

1.

Dual pharmacological inhibitor of endocannabinoid degrading enzymes reduces depressive-like behavior in female rats.

Dong B, Shilpa BM, Shah R, Goyal A, Xie S, Bakalian MJ, Suckow RF, Cooper TB, Mann JJ, Arango V, Vinod KY.

J Psychiatr Res. 2019 Oct 11;120:103-112. doi: 10.1016/j.jpsychires.2019.10.010. [Epub ahead of print]

PMID:
31654971
2.

Corrigendum to"Ketamine metabolite pilot study in a suicidal depression trial" [J Psychiatr Res 117 (2019) 129-134. doi: 10.1016/j.jpsychires.2019.08.005. Epub 2019 Aug 9].

Grunebaum MF, Galfalvy HC, Choo TH, Parris MS, Burke AK, Suckow RF, Cooper TB, Mann JJ.

J Psychiatr Res. 2019 Dec;119:32. doi: 10.1016/j.jpsychires.2019.09.008. Epub 2019 Sep 21. No abstract available.

PMID:
31550622
3.

Ketamine metabolite pilot study in a suicidal depression trial.

Grunebaum MF, Galfalvy HC, Choo TH, Parris MS, Burke AK, Suckow RF, Cooper TB, Mann JJ.

J Psychiatr Res. 2019 Oct;117:129-134. doi: 10.1016/j.jpsychires.2019.08.005. Epub 2019 Aug 9. Erratum in: J Psychiatr Res. 2019 Dec;119:32.

PMID:
31415914
4.

Brain serotonin transporter binding, plasma arachidonic acid and depression severity: A positron emission tomography study of major depression.

Gopaldas M, Zanderigo F, Zhan S, Ogden RT, Miller JM, Rubin-Falcone H, Cooper TB, Oquendo MA, Sullivan G, Mann JJ, Sublette ME.

J Affect Disord. 2019 Oct 1;257:495-503. doi: 10.1016/j.jad.2019.07.035. Epub 2019 Jul 5.

PMID:
31319341
5.

Cortisol Stress Response and in Vivo PET Imaging of Human Brain Serotonin 1A Receptor Binding.

Steinberg LJ, Rubin-Falcone H, Galfalvy HC, Kaufman J, Miller JM, Sublette ME, Cooper TB, Min E, Keilp JG, Stanley BH, Oquendo MA, Ogden RT, Mann JJ.

Int J Neuropsychopharmacol. 2019 May 1;22(5):329-338. doi: 10.1093/ijnp/pyz009.

6.

Maternal Cerebrospinal Fluid Glutamate in Response to Variable Foraging Demand: Relationship to Cerebrospinal Fluid Serotonin Metabolites in Grown Offspring.

Coplan JD, Gupta NK, Flynn SK, Reiner WJ, Gaita D, Fulton SL, Rozenboym AV, Tang JE, Cooper TB, Mann JJ.

Chronic Stress (Thousand Oaks). 2018 Jan-Dec;2. doi: 10.1177/2470547018785625. Epub 2018 Jul 6.

7.

Bilateral Locking of the Metacarpophalangeal Joint: A Case Report and Systematic Literature Review.

Poonit K, Zhao B, Jin Z, Yuan K, Cooper TB, Yan H.

Ann Plast Surg. 2018 Nov;81(5):531-536. doi: 10.1097/SAP.0000000000001593.

PMID:
30161044
8.

Effects of Rapastinel (Formerly GLYX-13) on Serum Brain-Derived Neurotrophic Factor in Obsessive-Compulsive Disorder.

Linkovski O, Shen H, Zwerling J, Filippou-Frye M, Jo B, Cordell E, Cooper TB, Simpson HB, Burch RM, Moskal JR, Lee F, Rodriguez CI.

J Clin Psychiatry. 2018 Jan/Feb;79(1). pii: 17l11824. doi: 10.4088/JCP.17l11824. No abstract available.

9.

Ketamine versus midazolam in bipolar depression with suicidal thoughts: A pilot midazolam-controlled randomized clinical trial.

Grunebaum MF, Ellis SP, Keilp JG, Moitra VK, Cooper TB, Marver JE, Burke AK, Milak MS, Sublette ME, Oquendo MA, Mann JJ.

Bipolar Disord. 2017 May;19(3):176-183. doi: 10.1111/bdi.12487. Epub 2017 Apr 28.

PMID:
28452409
10.

Lipid correlates of antidepressant response to omega-3 polyunsaturated fatty acid supplementation: A pilot study.

Ganança L, Galfalvy HC, Oquendo MA, Hezghia A, Cooper TB, Mann JJ, Sublette ME.

Prostaglandins Leukot Essent Fatty Acids. 2017 Apr;119:38-44. doi: 10.1016/j.plefa.2017.03.004. Epub 2017 Mar 10.

11.

The recency ratio is associated with reduced CSF glutamate in late-life depression.

Bruno D, Nierenberg J, Cooper TB, Marmar CR, Zetterberg H, Blennow K, Hashimoto K, Pomara N.

Neurobiol Learn Mem. 2017 May;141:14-18. doi: 10.1016/j.nlm.2017.03.011. Epub 2017 Mar 18.

12.

Modulating NMDA Receptor Function with D-Amino Acid Oxidase Inhibitors: Understanding Functional Activity in PCP-Treated Mouse Model.

Sershen H, Hashim A, Dunlop DS, Suckow RF, Cooper TB, Javitt DC.

Neurochem Res. 2016 Feb;41(1-2):398-408. doi: 10.1007/s11064-016-1838-8. Epub 2016 Feb 8.

13.

Omega-3 polyunsaturated fatty acid supplementation and white matter changes in major depression.

Chhetry BT, Hezghia A, Miller JM, Lee S, Rubin-Falcone H, Cooper TB, Oquendo MA, Mann JJ, Sublette ME.

J Psychiatr Res. 2016 Apr;75:65-74. doi: 10.1016/j.jpsychires.2015.12.007. Epub 2016 Jan 11.

14.

Further evidence of low baseline cortisol levels in suicide attempters.

Keilp JG, Stanley BH, Beers SR, Melhem NM, Burke AK, Cooper TB, Oquendo MA, Brent DA, John Mann J.

J Affect Disord. 2016 Jan 15;190:187-192. doi: 10.1016/j.jad.2015.10.012. Epub 2015 Oct 23.

PMID:
26519639
15.

Blunted HPA Axis Activity in Suicide Attempters Compared to those at High Risk for Suicidal Behavior.

Melhem NM, Keilp JG, Porta G, Oquendo MA, Burke A, Stanley B, Cooper TB, Mann JJ, Brent DA.

Neuropsychopharmacology. 2016 May;41(6):1447-56. doi: 10.1038/npp.2015.309. Epub 2015 Oct 9.

16.

A pilot in vivo proton magnetic resonance spectroscopy study of amino acid neurotransmitter response to ketamine treatment of major depressive disorder.

Milak MS, Proper CJ, Mulhern ST, Parter AL, Kegeles LS, Ogden RT, Mao X, Rodriguez CI, Oquendo MA, Suckow RF, Cooper TB, Keilp JG, Shungu DC, Mann JJ.

Mol Psychiatry. 2016 Mar;21(3):320-7. doi: 10.1038/mp.2015.83. Epub 2015 Aug 18.

17.

DNA methylation perturbations in genes involved in polyunsaturated Fatty Acid biosynthesis associated with depression and suicide risk.

Haghighi F, Galfalvy H, Chen S, Huang YY, Cooper TB, Burke AK, Oquendo MA, Mann JJ, Sublette ME.

Front Neurol. 2015 Apr 28;6:92. doi: 10.3389/fneur.2015.00092. eCollection 2015.

18.

Low plasma eicosapentaenoic acid levels are associated with elevated trait aggression and impulsivity in major depressive disorder with a history of comorbid substance use disorder.

Beier AM, Lauritzen L, Galfalvy HC, Cooper TB, Oquendo MA, Grunebaum MF, Mann JJ, Sublette ME.

J Psychiatr Res. 2014 Oct;57:133-40. doi: 10.1016/j.jpsychires.2014.06.012. Epub 2014 Jun 26.

19.

Association of testosterone levels and future suicide attempts in females with bipolar disorder.

Sher L, Grunebaum MF, Sullivan GM, Burke AK, Cooper TB, Mann JJ, Oquendo MA.

J Affect Disord. 2014 Sep;166:98-102. doi: 10.1016/j.jad.2014.04.068. Epub 2014 May 5.

20.

Anxiety in major depression and cerebrospinal fluid free gamma-aminobutyric acid.

Mann JJ, Oquendo MA, Watson KT, Boldrini M, Malone KM, Ellis SP, Sullivan G, Cooper TB, Xie S, Currier D.

Depress Anxiety. 2014 Oct;31(10):814-21. doi: 10.1002/da.22278. Epub 2014 May 27.

21.

Omega-3 polyunsaturated fatty acid (PUFA) status in major depressive disorder with comorbid anxiety disorders.

Liu JJ, Galfalvy HC, Cooper TB, Oquendo MA, Grunebaum MF, Mann JJ, Sublette ME.

J Clin Psychiatry. 2013 Jul;74(7):732-8. doi: 10.4088/JCP.12m07970.

22.

Combined dexamethasone suppression-corticotrophin-releasing hormone stimulation test in medication-free major depression and healthy volunteers.

Sher L, Oquendo MA, Burke AK, Cooper TB, Mann JJ.

J Affect Disord. 2013 Dec;151(3):1108-12. doi: 10.1016/j.jad.2013.06.049. Epub 2013 Jul 15.

PMID:
23866302
23.

Testosterone levels in suicide attempters with bipolar disorder.

Sher L, Grunebaum MF, Sullivan GM, Burke AK, Cooper TB, Mann JJ, Oquendo MA.

J Psychiatr Res. 2012 Oct;46(10):1267-71. doi: 10.1016/j.jpsychires.2012.06.016. Epub 2012 Jul 31.

24.

Dysfunction in fatty acid amide hydrolase is associated with depressive-like behavior in Wistar Kyoto rats.

Vinod KY, Xie S, Psychoyos D, Hungund BL, Cooper TB, Tejani-Butt SM.

PLoS One. 2012;7(5):e36743. doi: 10.1371/journal.pone.0036743. Epub 2012 May 14.

25.

Cannabinoid receptor 1 signaling in embryo neurodevelopment.

Psychoyos D, Vinod KY, Cao J, Xie S, Hyson RL, Wlodarczyk B, He W, Cooper TB, Hungund BL, Finnell RH.

Birth Defects Res B Dev Reprod Toxicol. 2012 Apr;95(2):137-50. doi: 10.1002/bdrb.20348. Epub 2012 Feb 6.

26.

Craniofacial features resembling frontonasal dysplasia with a tubulonodular interhemispheric lipoma in the adult 3H1 tuft mouse.

Fong KS, Cooper TB, Drumhiller WC, Somponpun SJ, Yang S, Ernst T, Chang L, Lozanoff S.

Birth Defects Res A Clin Mol Teratol. 2012 Feb;94(2):102-13. doi: 10.1002/bdra.22878. Epub 2012 Jan 13.

27.

Preliminary findings on the interactive effects of IV ethanol and IV nicotine on human behavior and cognition: a laboratory study.

Ralevski E, Perry EB Jr, D'Souza DC, Bufis V, Elander J, Limoncelli D, Vendetti M, Dean E, Cooper TB, McKee S, Petrakis I.

Nicotine Tob Res. 2012 May;14(5):596-606. doi: 10.1093/ntr/ntr258. Epub 2011 Dec 16.

28.

Nutritional supplements in critical illness.

Hayes GL, McKinzie BP, Bullington WM, Cooper TB, Pilch NA.

AACN Adv Crit Care. 2011 Oct-Dec;22(4):301-16; quiz 317-8. doi: 10.1097/NCI.0b013e31822c371b. Review.

PMID:
22064578
29.

Terlipressin in hepatorenal syndrome.

Mazur JE, Cooper TB, Dasta JF.

Ann Pharmacother. 2011 Mar;45(3):380-7. doi: 10.1345/aph.1P195. Epub 2011 Mar 8. Review.

PMID:
21386023
30.

Innate difference in the endocannabinoid signaling and its modulation by alcohol consumption in alcohol-preferring sP rats.

Vinod KY, Maccioni P, Garcia-Gutierrez MS, Femenia T, Xie S, Carai MA, Manzanares J, Cooper TB, Hungund BL, Colombo G.

Addict Biol. 2012 Jan;17(1):62-75. doi: 10.1111/j.1369-1600.2010.00299.x. Epub 2011 Feb 11.

31.

Validation of a food frequency questionnaire to assess intake of n-3 polyunsaturated fatty acids in subjects with and without major depressive disorder.

Sublette ME, Segal-Isaacson CJ, Cooper TB, Fekri S, Vanegas N, Galfalvy HC, Oquendo MA, Mann JJ.

J Am Diet Assoc. 2011 Jan;111(1):117-123.e1-2. doi: 10.1016/j.jada.2010.10.007.

32.

Antipsychotic-induced vacuous chewing movements and extrapyramidal side effects are highly heritable in mice.

Crowley JJ, Adkins DE, Pratt AL, Quackenbush CR, van den Oord EJ, Moy SS, Wilhelmsen KC, Cooper TB, Bogue MA, McLeod HL, Sullivan PF.

Pharmacogenomics J. 2012 Apr;12(2):147-55. doi: 10.1038/tpj.2010.82. Epub 2010 Nov 16.

33.

Combined catecholamine and indoleamine depletion following response to ECT.

Cassidy F, Weiner RD, Cooper TB, Carroll BJ.

Br J Psychiatry. 2010 Jun;196(6):493-4. doi: 10.1192/bjp.bp.109.070573.

PMID:
20513863
34.

No effect of dopamine depletion on the binding of the high-affinity D 2/3 radiotracer [11C]FLB 457 in the human cortex.

Frankle WG, Mason NS, Rabiner EA, Ridler K, May MA, Asmonga D, Chen CM, Kendro S, Cooper TB, Mathis CA, Narendran R.

Synapse. 2010 Dec;64(12):879-85. doi: 10.1002/syn.20806.

PMID:
20506387
35.

Increased synaptic dopamine function in associative regions of the striatum in schizophrenia.

Kegeles LS, Abi-Dargham A, Frankle WG, Gil R, Cooper TB, Slifstein M, Hwang DR, Huang Y, Haber SN, Laruelle M.

Arch Gen Psychiatry. 2010 Mar;67(3):231-9. doi: 10.1001/archgenpsychiatry.2010.10.

PMID:
20194823
36.

Selective alterations of the CB1 receptors and the fatty acid amide hydrolase in the ventral striatum of alcoholics and suicides.

Vinod KY, Kassir SA, Hungund BL, Cooper TB, Mann JJ, Arango V.

J Psychiatr Res. 2010 Jul;44(9):591-7. doi: 10.1016/j.jpsychires.2009.11.013. Epub 2009 Dec 16.

37.

Sex-specific effects of chronic fluoxetine treatment on neuroplasticity and pharmacokinetics in mice.

Hodes GE, Hill-Smith TE, Suckow RF, Cooper TB, Lucki I.

J Pharmacol Exp Ther. 2010 Jan;332(1):266-73. doi: 10.1124/jpet.109.158717. Epub 2009 Oct 14.

38.

Antidepressant response to electroconvulsive therapy is sustained after catecholamine depletion.

Cassidy F, Weiner RD, Cooper TB, Carroll BJ.

Prog Neuropsychopharmacol Biol Psychiatry. 2009 Aug 1;33(5):872-4. doi: 10.1016/j.pnpbp.2009.04.005. Epub 2009 Apr 17.

PMID:
19376184
39.

Positron emission tomography imaging of amphetamine-induced dopamine release in the human cortex: a comparative evaluation of the high affinity dopamine D2/3 radiotracers [11C]FLB 457 and [11C]fallypride.

Narendran R, Frankle WG, Mason NS, Rabiner EA, Gunn RN, Searle GE, Vora S, Litschge M, Kendro S, Cooper TB, Mathis CA, Laruelle M.

Synapse. 2009 Jun;63(6):447-61. doi: 10.1002/syn.20628.

PMID:
19217025
40.

Association of X-box binding protein 1 ( XBP1) genotype with morning cortisol and 1-year clinical course after a major depressive episode.

Grunebaum MF, Galfalvy HC, Huang YY, Cooper TB, Burke AK, Agnello M, Oquendo MA, Mann JJ.

Int J Neuropsychopharmacol. 2009 Mar;12(2):281-3. doi: 10.1017/S1461145708009863. Epub 2009 Jan 20.

41.

The apolipoprotein E epsilon4 allele and memory performance in HIV-1 seropositive subjects: differences at baseline but not after acute oral lorazepam challenge.

Pomara N, Belzer KD, Silva R, Cooper TB, Sidtis JJ.

Psychopharmacology (Berl). 2008 Nov;201(1):125-35. doi: 10.1007/s00213-008-1253-1. Epub 2008 Jul 31.

PMID:
18668226
42.

Serotonergic responses in depressed patients with or without a history of alcohol use disorders and healthy controls.

Sher L, Stanley BH, Cooper TB, Malone KM, Mann JJ, Oquendo MA.

Eur Neuropsychopharmacol. 2008 Sep;18(9):692-9. doi: 10.1016/j.euroneuro.2008.05.005. Epub 2008 Jun 30.

43.

Genetic and pharmacological manipulations of the CB(1) receptor alter ethanol preference and dependence in ethanol preferring and nonpreferring mice.

Vinod KY, Yalamanchili R, Thanos PK, Vadasz C, Cooper TB, Volkow ND, Hungund BL.

Synapse. 2008 Aug;62(8):574-81. doi: 10.1002/syn.20533.

44.

Future suicide attempt and responses to serotonergic challenge.

Keilp JG, Oquendo MA, Stanley BH, Burke AK, Cooper TB, Malone KM, Mann JJ.

Neuropsychopharmacology. 2010 Apr;35(5):1063-72. doi: 10.1038/npp.2008.28. Epub 2008 Mar 19.

45.
46.

Ethanol alters lipid profiles and phosphorylation status of AMP-activated protein kinase in the neonatal mouse brain.

Saito M, Chakraborty G, Mao RF, Wang R, Cooper TB, Vadasz C, Saito M.

J Neurochem. 2007 Nov;103(3):1208-18. Epub 2007 Aug 7.

47.

Transient cerebral hypoperfusion enhances intraarterial carmustine deposition into brain tissue.

Joshi S, Wang M, Etu JJ, Suckow RF, Cooper TB, Feinmark SJ, Bruce JN, Fine RL.

J Neurooncol. 2008 Jan;86(2):123-32. Epub 2007 Jul 17.

PMID:
17634743
48.

Positron emission tomography study of regional brain metabolic responses to a serotonergic challenge in major depressive disorder with and without comorbid lifetime alcohol dependence.

Sher L, Milak MS, Parsey RV, Carballo JJ, Cooper TB, Malone KM, Oquendo MA, Mann JJ.

Eur Neuropsychopharmacol. 2007 Sep;17(9):608-15. Epub 2007 May 2.

49.

Amphetamine-induced dopamine release: markedly blunted in cocaine dependence and predictive of the choice to self-administer cocaine.

Martinez D, Narendran R, Foltin RW, Slifstein M, Hwang DR, Broft A, Huang Y, Cooper TB, Fischman MW, Kleber HD, Laruelle M.

Am J Psychiatry. 2007 Apr;164(4):622-9.

PMID:
17403976
50.

Weight gain during a double-blind multidosage clozapine study.

de Leon J, Diaz FJ, Josiassen RC, Cooper TB, Simpson GM.

J Clin Psychopharmacol. 2007 Feb;27(1):22-7.

PMID:
17224708

Supplemental Content

Loading ...
Support Center